Roxane Bunod

Dr. Roxane Bunod


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2021 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
RBRoxane Bunod
Roxane Bunod
MRMathieu Robin
Mathieu Robin
JBJuliette Buffault
Juliette Buffault
CKChafik Keilani
Chafik Keilani
ALAntoine Labbé
Antoine Labbé
CBChristophe Baudouin
Christophe Baudouin
Background: PreserFlo® MicroShunt (PM) (also known as InnFocus® MicroShunt) is a subconjunctival stent implanted ab externo via a minimally invasive surgical procedure. The current indication is progressive, mild to moderate, open angle glaucoma uncontrolled on topical medications. According to the literature, adverse events are rare, mild and transient. Case presentation: Two cases of stand-alone PreserFlo MicroShunt® implantation in patients with uncontrolled open-angle glaucoma are reported. Exposure occurred 7 days and 3 months respectively after implantation. These cases shared common features including preexisting blepharitis and the lack of a Tenon’s flap. In both cases, removal of the device was required after several attempts at repair. Conclusions: PreserFlo MicroShunt® exposure is a potentially vision-threatening complication because of the risk of endophthalmitis. Potential risk factors include the absence of a Tenon’s flap and pre-existing ocular surface inflammation. Ocular surface inflammation should be detected and treated prior to PM implantation. If a deficiency in Tenon’s capsule is noted intraoperatively, close monitoring should be performed because of the higher risk of PM exposure.

3 January 2022 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
RBRoxane Bunod
Roxane Bunod
EAE. Augstburger
E. Augstburger
EBE. Brasnu
E. Brasnu
ALA. Labbe
A. Labbe
CBC. Baudouin
C. Baudouin

11 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RBRoxane Bunod
Roxane Bunod
AMAlexandra Mouallem-Beziere
Alexandra Mouallem-Beziere
FAFrancesca Amoroso
Francesca Amoroso
VCVittorio Capuano
Vittorio Capuano
KBKaren Bitton
Karen Bitton
Alexandra MiereAlexandra Miere
Alexandra Miere
Purpose: To evaluate the sensitivity and specificity of ultrawide-field fundus photography (UWF-FP) for the detection and classification of sickle cell retinopathy (SCR) by ophthalmologists with varying degrees of expertise in retinal disease. Methods: Patients presenting with sickle cell disease (SCD) in the Créteil University Eye Clinic, having undergone UWF-FP and ultrawide-field fluorescein angiography (UWF-FA) on the same day, were retrospectively included. Eyes with previous retinal photocoagulation were excluded. SCR was graded independently by UWF-FP and UWF-FA using Goldberg classification by two ophthalmologists with varying expertise levels. Results: Sixty-six eyes of 33 patients were included in the study. The sensitivity of UWF-FP for the detection of proliferative SCR was 100%, (95% confidence interval [CI95%] 76.8–100) for the retinal specialist and 100% (CI95% 71.5–100) for the ophthalmology resident. The specificity of UWF-FP for the detection of proliferative SCR was 100% (CI95% 92.7–100) for the retinal specialist and 98.1% (CI95% 89.7–100) for the ophthalmology resident. Conclusions: UWF-FP is a valuable exam for proliferative SCR screening, with excellent sensitivity and specificity and a good inter-grader agreement for ophthalmologists with various degree of skills, and is easy to use in a real-life setting.

1 November 2021 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
RBRoxane Bunod
Roxane Bunod
RHRachid Tahiri Joutei Hassani
Rachid Tahiri Joutei Hassani
MRM. Robin
M. Robin
HLH. Liang
H. Liang
GRG. Rabut
G. Rabut
ALA. Labbé
A. Labbé